The Valley Desk

NCT02415127 · Interventional trial

Safety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich's Ataxia

Overall registry status Completed

Phase 3

Conditions Friedreich's Ataxia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov